1631 related articles for article (PubMed ID: 19084658)
1. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation.
Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M
Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
Platzer DJ; White BA
J Pharm Biomed Anal; 2006 Apr; 41(1):84-8. PubMed ID: 16298506
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a reversed-phase HPLC method for simultaneous estimation of ambroxol hydrochloride and azithromycin in tablet dosage form.
Shaikh KA; Patil SD; Devkhile AB
J Pharm Biomed Anal; 2008 Dec; 48(5):1481-4. PubMed ID: 18993009
[TBL] [Abstract][Full Text] [Related]
4. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC.
Arayne MS; Sultana N; Siddiqui FA
Pak J Pharm Sci; 2006 Oct; 19(4):326-9. PubMed ID: 17105713
[TBL] [Abstract][Full Text] [Related]
6. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.
Shao Y; Alluri R; Mummert M; Koetter U; Lech S
J Pharm Biomed Anal; 2004 May; 35(3):625-31. PubMed ID: 15137989
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of alfuzosin hydrochloride in pharmaceutical formulations by RP-HPLC.
Ganesh M; Uppatyay S; Tivari R; Kamalakannan K; Rathinavel G; Gangully S; Sivakumar T
Pak J Pharm Sci; 2009 Jul; 22(3):263-6. PubMed ID: 19553171
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method.
A K; G S; C MR; Bhat K; A R; P M; M S; K K; N U
Pak J Pharm Sci; 2008 Oct; 21(4):421-5. PubMed ID: 18930865
[TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by high-performance liquid chromatography.
Xu X; Fu Y; Hu H; Duan Y; Zhang Z
J Pharm Biomed Anal; 2006 Apr; 41(1):266-73. PubMed ID: 16303273
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a HPLC method for the analysis of promethazine hydrochloride in hot-melt extruded dosage forms.
Thumma S; Zhang SQ; Repka MA
Pharmazie; 2008 Aug; 63(8):562-7. PubMed ID: 18771002
[TBL] [Abstract][Full Text] [Related]
11. Multivariate optimization and validation of an analytical methodology by RP-HPLC for the determination of losartan potassium in capsules.
Bonfilio R; Tarley CR; Pereira GR; Salgado HR; de Araújo MB
Talanta; 2009 Nov; 80(1):236-41. PubMed ID: 19782220
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a HPLC-UV method for the determination in didanosine tablets.
de Oliveira AM; Löwen TC; Cabral LM; dos Santos EM; Rodrigues CR; Castro HC; dos Santos TC
J Pharm Biomed Anal; 2005 Jul; 38(4):751-6. PubMed ID: 15967304
[TBL] [Abstract][Full Text] [Related]
13. The simultaneous separation and determination of five quinolone antibiotics using isocratic reversed-phase HPLC: application to stability studies on an ofloxacin tablet formulation.
Shervington LA; Abba M; Hussain B; Donnelly J
J Pharm Biomed Anal; 2005 Sep; 39(3-4):769-75. PubMed ID: 15953703
[TBL] [Abstract][Full Text] [Related]
14. RP-HPLC method and its validation for the determination of naloxone from a novel transdermal formulation.
Panchagnula R; Sharma P; Khandavilli S; Varma MV
Farmaco; 2004 Oct; 59(10):839-42. PubMed ID: 15474062
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms.
Karakuş S; Küçükgüzel I; Küçükgüzel SG
J Pharm Biomed Anal; 2008 Jan; 46(2):295-302. PubMed ID: 18054459
[TBL] [Abstract][Full Text] [Related]
16. Validated stability-indicating HPLC method for the determination of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) and its degradation products.
Hadad GM
J Pharm Biomed Anal; 2008 Aug; 47(4-5):695-703. PubMed ID: 18403161
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations.
Kyriakides D; Panderi I
Anal Chim Acta; 2007 Feb; 584(1):153-9. PubMed ID: 17386598
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms.
Sistla R; Tata VS; Kashyap YV; Chandrasekar D; Diwan PV
J Pharm Biomed Anal; 2005 Sep; 39(3-4):517-22. PubMed ID: 15936912
[TBL] [Abstract][Full Text] [Related]
19. Validation of a high-performance liquid chromatographic method for the simultaneous determination of tramadol and its impurities in oral drops as a pharmaceutical formulation.
Zecević M; Stanković Z; Zivanović Lj; Jocić B
J Chromatogr A; 2006 Jun; 1119(1-2):251-6. PubMed ID: 16386751
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of RP HPLC method to determine nandrolone phenylpropionate in different pharmaceutical formulations.
Mukherjee J; Das A; Chakrabarty US; Sahoo BK; Dey G; Choudhury H; Pal TK
Acta Pol Pharm; 2011; 68(2):155-60. PubMed ID: 21485287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
